Mark Roberts, Interviewer and Senior Editor at Traders News Source Interviewed, President & CEO Paul Cowley of Phenom Resources Corp. (OTCQX: PHNM...
Traders News Source Editor, Mark Roberts Recently had an Opportunity to Interview CEO, John Cash of Ur-Energy Inc. (NYSE American: URG)
Mark Roberts, Interviewer and Senior Editor at Traders News Source Interviewed, John W. Cash Chief Executive Officer at UR-Energy Inc. Mr. Cash was na...
Altamira Therapeutics (NASDAQ: CYTO) Biotech With Near-Term Catalysts Lining Up
This one could swing quickly, look at the chart setup. M&A activity in the RNA sector is strong. See list of near-term catalysts below Good day ev...
A Biopharma Company Working in a Big Market Sector with Novel Technology, Extremely Small Float, Trading Under $1/Share
Fed Chair Powell’s Recent Comments New Report will be Ready to Release Tomorrow at Market Open. A Biopharma Company Working in a Big Market Sector wit...
Swing Setup, RSI (14) 26.38, Book Value $1.85/Share, Current Price .57/Share
Grom Social (GROM) Subsidiary Curiosity Ink Media and Dynamite Entertainment Team Up with the U.S. Postal Service to Deliver New MR. ZIP™ Book ...
Mark Roberts, Senior Editor at Traders News Source Interviews Larry Heaton, CEO of Zomedica Corp. (NYSE American: ZOM)
Mark Roberts, Senior Editor at Traders News Source Interviews Larry Heaton, CEO of Zomedica Corp. (NYSE American: ZOM) Larry Heaton, CEO Zomedica Corp...
One of our recent winners has experienced a significant pull back in value and I think a solid case can be made for a near term upswing. I’m seeing revenue growth in 2022, and some good financial metrics to support that view. This report will be available tomorrow 5-17-22 at market open.
Should You Be Buying in the Current Market? Some Would Say Absolutely Yes, But There’s a Need to Be Selective. One of our recent winners has experienc...
Citius Pharma (NASDAQ: CTXR) Has Two Phase III Drugs with Big Potential Markets Looking at the FDA Finish Line
Good day everyone, Citius Pharmaceuticals, Inc. (NASDAQ: CTXR), is a late-stage biopharmaceutical company focused on oncology, anti-infective products...
Biopharma Companies Are Rebounding and We’ve Got a Real Gem to Discuss
You do not want to miss this one! We will issue this report on Thursday, May 5, 2022, at or near the market open. Good day everyone, Stocks have been ...
Traders News Source Editor Mark Roberts Had An Opportunity to Interview CEO, Pradyum Sekar of Skylight Health Group Inc. (NASDAQ: SLHG)
Traders News Source Editor, Mark Roberts Had An Opportunity to Interview CEO, Pradyum Sekar of Skylight Health Group Inc. (NASDAQ: SLHG) Full Transcri...